While most people associate hormone therapy with menopause, there is increasing recognition that hormonal fluctuations earlier in the reproductive life cycle may benefit from hormone stabilisation. This blog explores how hormone therapy can support women suffering from Premenstrual Syndrome (PMS ) and Premenstrual Dysphoric Disorder (PMDD), what the evidence says and how to navigate treatment with a specialist.
What Are PMS & PMDD?
PMS affects a high proportion of women of reproductive age; estimates suggest up to ~24% of women experience moderate symptoms and around 5–8% of women suffer PMDD, the severe cyclical mood and physical disorder. pms.org.uk+2pms.org.uk+2
PMDD is defined when mood symptoms (e.g., irritability, low mood, anxiety) occur in the luteal phase and substantially impair functioning, resolving shortly after the onset of menstruation. cks.nice.org.uk+1
Why Hormone Therapy Might Help
Research suggests that in PMS & PMDD the core issue is sensitivity to hormonal fluctuations, particularly oestrogen and progesterone, rather than simple hormone deficiency. pms.org.uk+1
Hormone therapy (such as continuous oestrogen or progesterone methods) aims to ease the cycle of peaks and troughs, thereby reducing the trigger of symptoms. pms.org.uk+1
Types of Hormonal Approaches
- Continuous combined oral contraceptives (COCs) or extended-cycle contraceptives to suppress cyclical variation. pms.org.uk+1
- Transdermal oestrogen plus progestogen. pms.org.uk+1
- Specialist endocrine or gynaecological referral when standard treatments fail.
Evidence and Clinical Practice
While guidelines emphasise non-hormonal options such as SSRI antidepressants, lifestyle & CBT as first-line, hormonal therapy is increasingly used to improve symptoms and quality of life in women with PMDD particularly if symptoms are progressing across more of the cycle in the approach to perimenopause and menopause. rcog.org.uk+1
A treatment pathway may include monitoring symptom patterns and severity then initiating hormonal stabilisation alongside lifestyle interventions and monitoring impact.
Who Might Benefit
- Women with cyclical mood or physical symptoms such as irritability, low mood (including suicidal thoughts), anxiety, panic, breast pain and bloating that is strongly linked to the second half (luteal phase) of menstrual cycles.
- Those diagnosed with PMDD (≥5 symptoms including mood, causing impairment) and standard treatments have not sufficed.
Safety, Monitoring & Specialist Care
Hormone therapy for PMS and PMDD requires the same caution as other hormone treatments: screening for risk factors such as migraine, blood clots or liver health problems, cardiovascular disease, liver disease, breast cancer risk, and lifestyle review. Shared decision-making is essential.
Local & Remote Support
If you’re experiencing severe PMS or PMDD and considering hormone therapy, specialist assessment is available via The Menopause Medic in Berkhamsted, St Albans, and via remote consultations across Watford, Hemel Hempstead, Harpenden, Tring, Welwyn Garden City and surrounding areas.
References
- RCOG Green-Top Guideline No 48, Management of PMS/PMDD: https://www.rcog.org.uk/guidance rcog.org.uk+1
- NICE CKS – PMS management: https://cks.nice.org.uk/topics/premenstrual-syndrome/management cks.nice.org.uk
- NAPS guidelines – PMS/PMDD modern management: https://www.pms.org.uk/app/uploads/2023/11/Panay.pdf pms.org.uk
